CHOLESTASIS
Clinical trials for CHOLESTASIS explained in plain language.
Never miss a new study
Get alerted when new CHOLESTASIS trials appear
Sign up with your email to follow new studies for CHOLESTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for relieving severe itch in liver disease
Symptom relief OngoingThis study tests the long-term safety of linerixibat, a drug for severe itching caused by primary biliary cholangitis (PBC). All 242 participants receive the drug openly. The goal is to see if it remains safe over time and improves quality of life.
Matched conditions: CHOLESTASIS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Tiny blood cells may reveal clues about liver disease in kids
Knowledge-focused OngoingThis pilot study looks at red blood cells in 20 children with cholestatic liver disease and compares them to healthy children. Researchers use a special test called ektacytometry to measure how fragile and flexible the red blood cells are. The goal is to see if liver problems cha…
Matched conditions: CHOLESTASIS
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC